🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to obtain information on efficacy, safety and ...
Status
Unknown
Location
West Hospital, Sichuan University
Start Date
2014-04
Trial ID
NCT02403440
Treatments Being Tested
This is a single-center, single-arm, open-label, self-controlled, phase I c...
Status
Completed
Location
West China Second University Hospital Ethics Committee
Start Date
2020-09-03
Trial ID
NCT05088174
Treatments Being Tested
This study use a single-center, randomized, open, three-cycle, self-control...
Status
Completed
Location
The third xiangya hospital Hospital,of central south university
Start Date
2018-07-14
Trial ID
NCT03603132
Treatments Being Tested
This open-label, randomized, two-period, two-treatment (single doses of 7.5...
Status
Completed
Location
West Hospital, Sichuan University
Start Date
2014-03
Trial ID
NCT02409394
Treatments Being Tested
This is a Multicentre, Open-label, single-arm, Phase II Study to Evaluate t...
Status
Completed
Location
Blood Diseases Hospital, Chinese Academy of Medical Sciences
Start Date
2018-06-20
Trial ID
NCT03557099
Treatments Being Tested
A multicentre, randomised, double-blind,4-stages phase III study enrolled 4...
Status
Completed
Location
Union Hospital Tongji Medical College Huazhong University of Science and technology
Start Date
2017-06-30
Trial ID
NCT03222843
Treatments Being Tested
To evaluate the efficacy and safety of hetrombopag in the treatment of thro...
Status
Unknown
Location
xianglin Yuan
Start Date
2022-10
Trial ID
NCT05575986
Treatments Being Tested
This study consists of two parts. Part 1 is a pilot BE study, and Part 2 is...
Status
Completed
Location
The People's Hospital Of Liaoning Province
Start Date
2021-06-25
Trial ID
NCT05088655
Treatments Being Tested
This is a multicenter, randomized, placebo-control, phase III study to inve...
Status
Completed
Location
Blood Diseases Hospital, Chinese Academy of Medical Sciences
Start Date
2019-03-05
Trial ID
NCT03825744
Treatments Being Tested
This study is a single-center, open-label, single-dose design. It is planni...
Status
Completed
Location
The first affiliated hospital of Suzhou university
Start Date
2019-05-25
Trial ID
NCT03977805
Treatments Being Tested